# Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

> **NCT05121532** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 60 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DIAGNOSTIC_TEST:** Interleukin-15 and Interleukin-22

## Key facts

- **NCT ID:** NCT05121532
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121532, "Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05121532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*